Zuclopenthixol Acetate (Clopixol Acuphase) Monitoring Guideline

Name/Title

Zuclopenthixol Acetate (Clopixol Acuphase) Monitoring Guideline (PDF)

Document ID

TS4KSNFPVEZQ-210-16850

Current from

09/08/2018

Coverage

WACHS

Policy Type

Guideline

Summary

This guideline sets out how Zuclopenthixol acetate (Clopixol Acuphase) - an intermediate acting intramuscular injection, indicated in managing acute psychosis or mania in adults, is administered in a Mental Health Inpatient Unit (only).

FEEDBACK

ON OUR SERVICES

FEEDBACK

ABOUT THIS WEBSITE